Lying‑Sitting‑Standing Baduanjin to improve heart and lung function in acute coronary syndrome with heart failure
Official title: A Clinical Study on the Effect of Cardiopulmonary Function and Quality of Life in Patients With Acute Coronary Syndrome Complicated by Heart Failure by "Lying-Sitting-Standing" Sequential Baduanjin
Run by Second Hospital of Shanxi Medical University · NCT07486791 · Data updated 2026-11-12
This study will test whether a gentle sequence of Baduanjin exercises performed lying, sitting, and standing helps people hospitalized with acute coronary syndrome and heart failure improve heart and lung function and quality of life.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | Any age to 85 Years |
| Sex | All |
| Enrollment | 65 (estimated) |
| Sponsor | Second Hospital of Shanxi Medical University Academic / other |
| Locations | 1 site (Taiyuan, Shanxi) |
| Status | Recruiting |
| Started | March 10, 2026 |
| Main results expected | March 1, 2027 |
| Study ends | June 1, 2027 |
| Registry record updated | May 5, 2026 |
| Trial ID | NCT07486791 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are people hospitalized with ACS who develop heart failure, are age 85 or younger, have at least grade‑3 muscle strength, are conscious, and can provide informed consent.
✕Probably not a fit
Patients with persistent NYHA class IV symptoms despite optimal therapy, uncontrolled arrhythmias or hypertension, hemodynamic instability, untreated structural heart disease, or other acute severe illnesses are unlikely to benefit or be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Participants with acute coronary syndrome complicated by heart failure will receive standard medical treatment and routine rehabilitation nursing guidance, with some patients also doing a sequential lying‑sitting‑standing Baduanjin exercise program. The intervention group will perform the Baduanjin sequence alongside usual care while the comparison group receives usual care alone. Cardiopulmonary function and quality of life will be measured using echocardiography, NT‑proBNP, 6‑minute walk test, NYHA class, and the SF‑36 questionnaire. Results will be compared to see if this low‑intensity exercise sequence can be a viable early cardiac rehabilitation option.
Why it matters
Potential benefit: If effective, this simple, low‑cost exercise sequence could improve cardiopulmonary function and quality of life and offer a practical early cardiac rehabilitation option for these patients.
How similar studies have gone: Previous smaller studies of Baduanjin and similar Qigong exercises have shown promise for cardiac rehabilitation outcomes, but the specific lying‑sitting‑standing sequential approach is relatively novel and less studied.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients meeting the diagnostic criteria for ACS (including unstable angina, non-ST-segment elevation myocardial infarction, and ST-segment elevation myocardial infarction) * Complicated by heart failure during hospitalization * Age ≤ 85 years * Muscle strength ≥ grade 3 * No history of mental illness, conscious and able to cooperate independently with this study * Voluntarily participate in this study and sign the informed consent form Exclusion Criteria: * Patients with persistent heart failure symptoms or NYHA functional class IV despite optimal pharmacological therapy; * Patients with contraindications to cardiac rehabilitation, such as uncontrolled hypertension, uncontrolled arrhythmias, or hemodynamic instability; * Patients with untreated structural heart disease, such as heart failure caused by valvular heart disease or congenital heart disease; * Patients in the acute phase of various diseases, such as severe infection, deep vein thrombosis, or severe hepatic or renal failure; * Patients with disabilities, bone or joint diseases, or neurological disorders that preclude participation in Baduanjin exercises; * Patients with a life expectancy of less than one year; * Patients currently participating in other clinical trials.
Where it's running
-
Second Hospital of Shanxi Medical
Taiyuan, Shanxi, China Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
EHR-guided LDL cholesterol optimization after a heart event
A pharmacist-guided program using electronic health records to help adults in Alberta reach LDL goals after a heart event by adjusting medications and ordering tests.
-
AI ECG test to spot LV dysfunction in adults
A deep learning ECG tool is being tested to see if it can reliably flag left ventricular systolic dysfunction (LVEF ≤40%) in adults who also have an echocardiogram.
-
Dapagliflozin for Coronary Inflammation in Stage 4 CKM Syndrome After ACS
This trial tests whether daily dapagliflozin can lower heart artery inflammation and slow plaque growth in adults with stage 4 CKM syndrome after acute coronary syndrome.
-
EuroHeart Italy registry for acute coronary syndrome, heart failure, and atrial fibrillation
This project will collect health information to see if following ESC quality indicators improves care for adults treated for acute coronary syndrome, heart failure, or atrial fibrillation.
-
Outcomes after PCI using the Protégé paclitaxel drug-coated balloon.
This registry will collect real-world data to see if the Protégé paclitaxel drug-coated balloon works well and is safe for adults having PCI for coronary artery disease or acute coronary syndrome.
-
Cardiovascular problems after allogeneic stem cell transplant
This study looks at heart-related problems after allogeneic hematopoietic stem cell transplantation to see how often they occur and what factors might predict them.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.